Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03569592 · ClinicalTrials.gov registry record · NA
Addressing Overdose Risk Among Recently Incarcerated People Living With HIV/AIDS
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT03569592 is a NA study that has completed, run by Drexel University. The registered enrollment target is 120 participants.
The verdict
NCT03569592, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The overall objective of this study is to evaluate an educational overdose prevention intervention's effectiveness among incarcerated people living with HIV/AIDS, specifically within the context of other outcomes related to health and experiences after incarceration. Results will be used to develop tailored interventions to reduce overdose deaths among high-risk correctional populations. The research has the following aims: * Aim 1: Evaluate a pilot program to provide HIV+ inmates with 1:1 overdose prevention training while incarcerated; * Aim 2: Identify the criminal justice, health, and HIV-related factors associated with overdose risk; and * Aim 3: Describe the overdose risk experiences of HIV+ former inmates who use opioids after release.
Interventions
- BEHAVIORAL Overdose Prevention Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2018-01-22 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03569592
The ClinicalTrials.gov registry entry for NCT03569592 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Overdose Prevention Intervention is the first listed.
NCT03569592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03569592 about?
NCT03569592 is a clinical study titled "Addressing Overdose Risk Among Recently Incarcerated People Living With HIV/AIDS". The overall objective of this study is to evaluate an educational overdose prevention intervention's effectiveness among incarcerated people living with HIV/AIDS, specifically within the context of other outcomes related to health and experiences after incarceration. Results will be used to develop ...
What is the current status of trial NCT03569592?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2018-01-22. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT03569592?
The interventions under investigation include: Overdose Prevention Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03569592?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.